MX2007012814A - Metodo de tratamiento utilizando un antagonista de la hormona del crecimiento y un agonista de la somatostatina. - Google Patents
Metodo de tratamiento utilizando un antagonista de la hormona del crecimiento y un agonista de la somatostatina.Info
- Publication number
- MX2007012814A MX2007012814A MX2007012814A MX2007012814A MX2007012814A MX 2007012814 A MX2007012814 A MX 2007012814A MX 2007012814 A MX2007012814 A MX 2007012814A MX 2007012814 A MX2007012814 A MX 2007012814A MX 2007012814 A MX2007012814 A MX 2007012814A
- Authority
- MX
- Mexico
- Prior art keywords
- antagonist
- somatostatin agonist
- treatment
- autogel
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Se presenta un metodo para atenuar los efectos de la hormona del crecimiento (GH) en un paciente. El metodo consiste en que al paciente se le administre tanto un antagonista de la GH como un agonista de la somatostatina, ya sea en forma simultanea o separada, continua o periodica. En una modalidad preferida del metodo, una composicion de liberacion prolongada de un agonista de la somatostatina se administra una vez al mes, y una composicion que no es de liberacion prolongada de un antagonista de la GH se administra una vez a la semana.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67074005P | 2005-04-13 | 2005-04-13 | |
PCT/EP2006/003438 WO2006108667A2 (en) | 2005-04-13 | 2006-04-13 | Method of treatment using gh antagonist and somatostatin agonist |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007012814A true MX2007012814A (es) | 2008-01-22 |
Family
ID=36968804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007012814A MX2007012814A (es) | 2005-04-13 | 2006-04-13 | Metodo de tratamiento utilizando un antagonista de la hormona del crecimiento y un agonista de la somatostatina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090215676A1 (es) |
EP (1) | EP1874355A2 (es) |
JP (1) | JP2008535882A (es) |
CN (1) | CN101163505A (es) |
AU (2) | AU2006233715A1 (es) |
BR (1) | BRPI0609355A2 (es) |
CA (1) | CA2604381A1 (es) |
MX (1) | MX2007012814A (es) |
RU (1) | RU2397778C2 (es) |
WO (1) | WO2006108667A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103087182B (zh) * | 2013-02-06 | 2014-11-05 | 中国科学院过程工程研究所 | 一种定点修饰n-末端的聚乙二醇化生长激素拮抗剂及其制备方法 |
JP6869720B2 (ja) * | 2013-06-13 | 2021-05-12 | アンチセンス セラピューティクス リミテッド | 併用療法 |
EP3218395B1 (en) * | 2014-11-12 | 2022-01-05 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Treatment of hormonal disorders of growth |
KR102167827B1 (ko) * | 2017-12-20 | 2020-10-20 | 주식회사 알테오젠 | 신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질 |
CA3105470A1 (en) * | 2018-07-11 | 2020-01-16 | Ohio University | Peptide-based inhibitors of growth hormone action and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE455171T1 (de) * | 1995-09-21 | 2010-01-15 | Genentech Inc | Varianten des menschlichen wachstumshormons |
WO2005021023A1 (en) * | 2003-09-02 | 2005-03-10 | Pharmacia & Upjohn Company | Therapeutical conversion |
-
2006
- 2006-04-13 CN CNA2006800123486A patent/CN101163505A/zh active Pending
- 2006-04-13 BR BRPI0609355-8A patent/BRPI0609355A2/pt not_active IP Right Cessation
- 2006-04-13 CA CA002604381A patent/CA2604381A1/en not_active Abandoned
- 2006-04-13 AU AU2006233715A patent/AU2006233715A1/en not_active Abandoned
- 2006-04-13 JP JP2008505823A patent/JP2008535882A/ja active Pending
- 2006-04-13 MX MX2007012814A patent/MX2007012814A/es unknown
- 2006-04-13 EP EP06742584A patent/EP1874355A2/en not_active Withdrawn
- 2006-04-13 US US11/918,460 patent/US20090215676A1/en not_active Abandoned
- 2006-04-13 RU RU2007141935/14A patent/RU2397778C2/ru not_active IP Right Cessation
- 2006-04-13 WO PCT/EP2006/003438 patent/WO2006108667A2/en active Application Filing
-
2010
- 2010-12-20 AU AU2010257328A patent/AU2010257328A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2604381A1 (en) | 2006-10-19 |
RU2007141935A (ru) | 2009-05-20 |
RU2397778C2 (ru) | 2010-08-27 |
AU2010257328A1 (en) | 2011-01-20 |
CN101163505A (zh) | 2008-04-16 |
BRPI0609355A2 (pt) | 2010-03-30 |
EP1874355A2 (en) | 2008-01-09 |
WO2006108667A2 (en) | 2006-10-19 |
JP2008535882A (ja) | 2008-09-04 |
US20090215676A1 (en) | 2009-08-27 |
WO2006108667A3 (en) | 2007-05-03 |
AU2006233715A1 (en) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005107726A3 (en) | Method for the treatment of back pain | |
UA96308C2 (ru) | Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение | |
HK1096014A1 (en) | Transdermal hormone delivery system: compositions and methods | |
WO2005034859A3 (en) | Extended release formulations of opioids and method of use thereof | |
UA86621C2 (ru) | Антагонисты рецептора глюкагона, их получение и терапевтическое применение | |
TW200604168A (en) | Azaindoles useful as inhibitors of rock and other protein kinases | |
TW200607798A (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
WO2007111864A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
WO2007136577A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
TW200634006A (en) | Tetrahydroquinoline analogues as muscarinic agonists | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
WO2005084296A3 (en) | Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3 | |
WO2006017246A3 (en) | Compositions for delivering highly water soluble drugs | |
WO2004073653A8 (en) | Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same | |
WO2005009370A3 (en) | Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors | |
WO2005123116A3 (en) | Compositions and methods for treating or preventing oxalate-related disease | |
WO2006015259A3 (en) | Compounds and compositions as modulators of steroid hormone nuclear receptors | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
WO2005084295A3 (en) | Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 | |
MX2007012814A (es) | Metodo de tratamiento utilizando un antagonista de la hormona del crecimiento y un agonista de la somatostatina. | |
AU2003304238A1 (en) | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same | |
WO2006047392A3 (en) | Nicotinic-opioid synergy for analgesia | |
UA90718C2 (ru) | Новое применение агонистов печеночного рецептора х | |
MXPA05011410A (es) | Tratamiento de incontinencia con agonistas de 5htc2. | |
WO2007141306A3 (en) | Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |